Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Novo Nordisk Pharmatech A/S

Closing information (x1000 EUR)

Closing information 2023/12 2022/12 2021/12
Turnover 118,129 Less Arrow 80,452 More Arrow 83,251
Earnings before taxes 13,242 Less Arrow 6,624 More Arrow 19,729
Total assets 169,942 Less Arrow 130,026 Less Arrow 86,054
Current assets 84,922 Less Arrow 67,737 Less Arrow 33,219
Current liabilities 61,513 Less Arrow 31,498 Less Arrow 12,175
Equity capital 102,901 Less Arrow 92,737 Less Arrow 69,960
- share capital 1,342 More Arrow 1,345 Equal arrow 1,345
Employees (average) 150 Equal arrow 150 Equal arrow 150

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 60.6% More Arrow 71.3% More Arrow 81.3%
Turnover per employee 788 Less Arrow 536 More Arrow 555
Profit as a percentage of turnover 11.2% Less Arrow 8.2% More Arrow 23.7%
Return on assets (ROA)
Current ratio 138.1% More Arrow 215.1% More Arrow 272.8%
Return on equity (ROE) 12.9% Less Arrow 7.1% More Arrow 28.2%
Change turnover 37,856 Less Arrow -2,800 Less Arrow -6,542
Change turnover % 47% Less Arrow -3% Less Arrow -7%
Chg. No. of employees 0 Equal arrow 0 Equal arrow 0
Chg. No. of employees % 0% Equal arrow 0% Equal arrow 0%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.